Guggenheim Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,945
| Closed | -$1.08M | – | 1934 |
|
|
2024
Q3 | $1.08M | Sell |
10,945
-9,713
| -47% | -$960K | 0.01% | 1058 |
|
|
2024
Q2 | $1.92M | Hold |
20,658
| – | – | 0.01% | 825 |
|
|
2024
Q1 | $1.96M | Hold |
20,658
| – | – | 0.01% | 885 |
|
|
2023
Q4 | $1.84M | Hold |
20,658
| – | – | 0.01% | 873 |
|
|
2023
Q3 | $1.51M | Sell |
20,658
-227
| -1% | -$16.6K | 0.01% | 919 |
|
|
2023
Q2 | $1.74M | Sell |
20,885
-106
| -0.5% | -$8.82K | 0.01% | 914 |
|
|
2023
Q1 | $1.6M | Buy |
20,991
+4,099
| +24% | +$312K | 0.01% | 944 |
|
|
2022
Q4 | $1.4M | Buy |
16,892
+8,527
| +102% | +$708K | 0.01% | 1003 |
|
|
2022
Q3 | $664K | Buy |
+8,365
| New | +$664K | 0.01% | 1353 |
|